Archive for July 7th, 2011

SGEN panel in favour of Hodgkin lymphoma approval + PRAN CADX news

Jul 07, 2011 No Comments by

Seattle Genetics, Inc. (Nasdaq:SGEN) – The Oncologic Drugs Advisory Committee (ODAC) is meeting today to discuss the its Biologics License Applications (BLAs) for ADCETRIS(TM) (brentuximab vedotin). ODAC will review the BLA for the treatment of relapsed or refractory Hodgkin lymphoma during the morning session and the BLA for the treatment of relapsed or refractory systemic […]

Daily News Read more